Clinical Trials Browser

Not yet recruiting × Neovascularization, Pathologic × 90 days × Clear all

NCT07346404 2026-01-16

RUBIKID

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Neovascularization, Pathologic